J. Goldman & Co’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

J. Goldman & Co’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-200,000	Closed	-$101K	–	472
2018 Q2	$101K	Hold	200,000	–	–	0.01%	330
2018 Q1	$86K	Hold	200,000	–	–	﹤0.01%	329
2017 Q4	$76K	Buy	+200,000	New	+$75.9K	﹤0.01%	306
2014 Q3	–	Sell	-400,000	Closed	-$200K	–	402
2014 Q2	$200K	Hold	400,000	–	–	0.01%	223
2014 Q1	$124K	Buy	400,000 +200,000	+100%	+$74.3K	0.01%	237
2013 Q4	$68K	Sell	200,000 -60,000	-23%	-$72.5K	0.01%	207
2013 Q3	$525K	Hold	260,000	–	–	0.05%	230
2013 Q2	$494K	Buy	+260,000	New	+$457K	0.05%	212

J. Goldman & Co's GCVRZ Position: Q3 2018 in Review

J. Goldman & Co sold out of Sanofi Contingent Value Rights (GCVRZ) in Q3 2018, closing a stake of 200,000 shares — an estimated $101K sold.

J. Goldman & Co first reported a position in GCVRZ in Q2 2013 and held it in 8 quarters. The position peaked at $525K in Q3 2013. 106 funds tracked by Wall St. Rank hold GCVRZ as of Q3 2018.

J. Goldman & Co reported no remaining Sanofi Contingent Value Rights position as of Q3 2018 after selling out during the quarter.
J. Goldman & Co sold 200,000 Sanofi Contingent Value Rights shares in Q3 2018, an estimated $101K.
J. Goldman & Co first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 8 quarters.
J. Goldman & Co's Sanofi Contingent Value Rights position peaked at $525K in Q3 2013.
106 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q3 2018.

Based on J. Goldman & Co's 13F filing for Q3 2018, filed 14 Nov 2018.